“Recently I decided to take on a new role, after being contacted by Ewan. From the very first point of contact until after signing the contract he has been nothing but supportive, and professional. I would recommend him for any type of recruitment process as I am certain he will deliver. Thanks again Ewan”
Global PMO Director, Sever Pharma Solutions
Mantell Associates recently appointed Ulrike Foley as VP of Global Business Development and Marketing at Sever Pharma Solutions. Ulrike brings more than 30 years of Business Development experience in the Pharmaceutical CDMO space. In her role as VP, she will take full responsibility of Sever Pharma Solutions’ global Business Development and Marketing function.
Sever Pharma Solutions brings your pharmaceutical ideas to life by offering expertise in high potent drug development, a drive to enhance performance, a passion for perfection, and a commitment to be your partner through the whole journey.
They add value through the entire development and manufacturing processes with in-depth analytics, expertise in high potent drugs and polymer-based drug delivery systems, comprehensive material options, and creative solutions.
By providing a complete value chain, from development to sourcing and worldwide commercial supply, they can offer you an optimized end-to-end solution. And as a committed long-term partner with a strong focus on creating a commercial product, they put all their resources at work for you to the finishing line – and beyond.
Together with their global GMP compliance, regulatory services, and market access strategies, they can secure that your products will benefit patients all over the world.
Company website – https://www.severpharmasolutions.com/
To find out more about Sever Pharma Solutions, contact Ewan Rennison on +44 (0)20 3854 7700 or ewan.rennison@mantellassociates.com.